SCHEMBL7308906

SCHEMBL7308906

COc1ccc(SC2(CC(=O)NO)CCN(C(=O)OCc3ccccc3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 5/20 0.51
MMP1 P03956 4/20 0.51
MMP3 P08254 4/20 0.51
MMP7 P09237 3/20 0.51
MMP2 P08253 1/20 0.51
MMP8 P22894 1/20 0.51
MMP13 P45452 2/20 0.50
SCN5A Q14524 1/20 0.46
SCN9A Q15858 1/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC3 O15379 2/20 0.46
HDAC2 Q92769 2/20 0.46
ADAM17 P78536 1/20 0.45
ADAM9 Q13443 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM1A O60341 2/20 0.43
GRIN2B Q13224 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303615 0.90 SCN5A (0.49) MMP9MMP1MMP3MMP7MMP2
SCHEMBL7301926 0.88 HDAC1 (0.43) MMP9MMP1MMP3MMP7MMP2
SCHEMBL7308120 0.81 OPRK1 (0.47) SCN5ASCN9AHDAC1HDAC6HDAC3
SCHEMBL7311907 0.79 P2RX7 (0.41) HDAC1HDAC6HDAC3HDAC2NPC1
SCHEMBL8423285 0.78 SCN5A (0.47) MMP9MMP1MMP3MMP7MMP2
SCHEMBL7308041 0.78 RORC (0.44) SCN5ASCN9AHDAC1HDAC6HDAC3
SCHEMBL8315425 0.75 OPRD1 (0.54) MMP9MMP1MMP3MMP7MMP2
SCHEMBL12050040 0.74 HTT (0.49) MMP9MMP1MMP3MMP7MMP2
SCHEMBL12050043 0.74 SCN5A (0.50) MMP9MMP1MMP3MMP7MMP2
SCHEMBL2472933 0.73 CHRM5 (0.50) SCN5ASCN9ANPC1GRIN2BAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed